Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Cash from Financing Activities (2023 - 2025)

Cannabis Bioscience International Holdings' Cash from Financing Activities history spans 3 years, with the latest figure at $156716.0 for Q2 2025.

  • For Q2 2025, Cash from Financing Activities fell 10.14% year-over-year to $156716.0; the TTM value through May 2025 reached $341824.0, down 27.46%, while the annual FY2025 figure was $341824.0, 27.46% down from the prior year.
  • Cash from Financing Activities for Q2 2025 was $156716.0 at Cannabis Bioscience International Holdings, up from $82358.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $216837.0 in Q4 2023 and bottomed at $9534.0 in Q1 2024.
  • The 3-year median for Cash from Financing Activities is $119537.0 (2025), against an average of $118690.2.
  • The largest annual shift saw Cash from Financing Activities plummeted 95.3% in 2024 before it skyrocketed 763.83% in 2025.
  • A 3-year view of Cash from Financing Activities shows it stood at $216837.0 in 2023, then tumbled by 66.74% to $72123.0 in 2024, then soared by 117.29% to $156716.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Cash from Financing Activities are $156716.0 (Q2 2025), $82358.0 (Q1 2025), and $72123.0 (Q4 2024).